References
- Halpin TF, Frick HC. Munnell EW. Critical points of failure in the therapy of cancer of the cervix: a reappraisal. Am J Obstet Gynecol 1972;114:755-764 https://doi.org/10.1016/0002-9378(72)90897-6
- Walsh JW, Amendola MA, Hall DJ, Tisnado J, Goplerud DR. Recurrent carcinoma of the cervix: CT diagnosis. AJR 1981;136:117-122 https://doi.org/10.2214/ajr.136.1.117
- Cunningham JJ, Fuks ZY, Castellino RA. Radiographic manifestations of carcinoma of the cervix and complications of its treatment. Radiol Clin North Am 1974;12:93-108
- Weber TM, Sostman HD, Spritzer CE, et al. Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imaging. Radiology 1995;194:135-139 https://doi.org/10.1148/radiology.194.1.7997540
- Hricak H, Swift PS, Campos Z, Quivey JM, Gildengorin V, Goranson H. Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging. Radiology 1993;189:381-388 https://doi.org/10.1148/radiology.189.2.8210364
- Williams MP, Husband JE, Heron CW, Cherryman GR, Koslin DB. Magnetic resonance imaging in recurrent carcinoma of the cervix. Br J Radiol 1989;62:544-550 https://doi.org/10.1259/0007-1285-62-738-544
- Flueckiger F, Ebner F, Poschauko H, Tamussino K, Einspieler R, Ranner G. Cervical cancer: serial MR imaging before and after primary radiation therapy-a 2-year follow-up study. Radiology 1992;184:89-93 https://doi.org/10.1148/radiology.184.1.1609108
- Di Chiro G. Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors-a powerful diagnostic and prognostic tool. Invest Radiol 1988;22:360-371 https://doi.org/10.1097/00004424-198705000-00002
- Carlson V, Delclos L, Fletcher GH. Distant metastases in squamous-cell carcinoma of the uterine cervix. Radiology 1967;88:961-966 https://doi.org/10.1148/88.5.961
- Keettel WC, Van Voorhis LW, Latourette HB. Management of recurrent carcinoma of the cervix. Am J Obstet Gynecol 1968;102:671-677 https://doi.org/10.1016/0002-9378(68)90381-5
- Hoh CK, Schiepers C, Seltzer MA, et al. PET in oncology: will it replace the other modalities? Semin Nucl Med 1997;27:94-106 https://doi.org/10.1016/S0001-2998(97)80042-6
- Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-141 https://doi.org/10.1148/radiology.200.1.8657901
- Bender H, Kirst J, Palmedo H, et al. Value of 18-fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma. Anticancer Res 1997;17:1687-1692
- Budinger TF, Brennan KM, Moses WW, Derenzo SE. Advances in positron tomography for oncology. Nucl Med Biol 1996;23:659-667 https://doi.org/10.1016/0969-8051(96)00063-7
- Blahd WH, Brown CV, Khonsary SA, et al. PET scans of abdominal malignancy. World J Surg 1996;20:245-247 https://doi.org/10.1007/s002689900039
- Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK Jr, Pinson CW. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 1998;133:510-516 https://doi.org/10.1001/archsurg.133.5.510
- Haseman MK, Reed NL, Rosenthal SA. Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation. Clin Nucl Med 1996;21:704-713 https://doi.org/10.1097/00003072-199609000-00007
- McGuirt WF, Greven KM, Keyes JW Jr, Williams DW 3rd, Watson N. Laryngeal radionecrosis versus recurrent cancer: a clinical approach. Ann Otol Rhinol Laryngol 1998;107:293-296 https://doi.org/10.1177/000348949810700406
- Miraldi F, Vesselle H, Faulhaber PF, Adler LP, Leisure GP. Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Clin Nucl Med 1998;23:3-7 https://doi.org/10.1097/00003072-199801000-00002
- Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 1997;4:613-620 https://doi.org/10.1007/BF02303744
- Greven KM, Williams DW 3rd, Keyes JW Jr, McGuirt WF, Watson NE Jr, Case LD. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Cancer J Sci Am 1997;3:353-357
- Garner CM. Positron emission tomography: new hope for early detection of recurrent brain tumors. Cancer Nurs 1997; 20:277-284 https://doi.org/10.1097/00002820-199708000-00008
- Schiepers C. Role of positron emission tomography in the staging of lung cancer. Lung Cancer 1997;17(S)1:29-35 https://doi.org/10.1016/S0169-5002(97)00638-7
- Simon GH, Nitzsche EU, Laubenberger JJ, Einert A, Moser E. PET imaging of recurrent medullary thyroid cancer. Nuklearmedizin 1996;35:102-104 https://doi.org/10.1055/s-0038-1629837
- Keogan MT, Lowe VJ, Baker ME, McDermott VG, Lyerly HK, Coleman RE. Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging. Abdom Imaging 1997;22:332-337 https://doi.org/10.1007/s002619900202
- Hudgins PA, Burson JG, Gussack GS, Grist WJ. CT and MR appearance of recurrent malignant head and neck neoplasms after resection and flap reconstruction. AJNR 1994;15: 1689-1694
- Vesselle HJ, Miraldi FD. FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. RadioGraphics 1998;18:805-823 https://doi.org/10.1148/radiographics.18.4.9672967